The role played by the interaction of nitric oxide (NO) and endothelins (ET) in the modulation of airway function, and the modulation of ad renergic-mediated bronchodilator responses by ascorbic acid in the presence or absence of endogenous NO induced by ET in anesthetized guinea-pigs was examined. Endothelins induced a concentration-dependent increase in respiratory resistance, and pretreatment with the NO synthase inhibitor, NG-nitro-L-arginine methylester, (L-NAME), significantly increased ET-mediated bronchoconstriction. In addition, ET-3-mediated bronchoconstriction following pretreatment with L-NAME was reversed by L-arginine. These findings suggest that the response to the administration of ET-3 can be attributed to the release of NO from the guinea-pig airway.
responses by ascorbic acid in the presence or absence of endogenous NO induced by ET in anesthetized guinea-pigs was examined. Endothelins induced a concentration-dependent increase in respiratory resistance, and pretreatment with the NO synthase inhibitor, NG-nitro-L-arginine methylester, (L-NAME), significantly increased ET-mediated bronchoconstriction. In addition, ET-3-mediated bronchoconstriction following pretreatment with L-NAME was reversed by L-arginine. These findings suggest that the response to the administration of ET-3 can be attributed to the release of NO from the guinea-pig airway.
Neither inhaled isoproterenol nor salbutamol significantly affected ET-3-mediated bronchoconstriction, but pretreatment with L-NAME markedly enhanced isoproterenol-mediated bronchodilatation. These findings suggest that endogenous NO induced by ET-3 may attenuate isoproterenol-mediated bronchodilator responses. Ascorbic acid, an antioxidant, enhanced isoproterenol-mediated bronchodilator responses following precontraction with ET-3, but pretreatment with L-NAME reduced this effect of ascorbic acid. The findings suggest that ascorbic acid attenuates the effect of endogenous NO on ad renergicmediated bronchodilator response via its antioxidant activity.
Since 10-7mol/L ET-1 does not induce the release of NO from the guinea-pig airway, ascorbic acid cannot enhance isopro- 
METHODS

Measurement of pulmonary resistance
Male Hartley guinea-pigs weighing 400-500g were used. Under sodium pentobarbital anesthesia (50 mg/kg, i. p.; Abbott Laboratories, IL, USA), artificial ventilation was performed through a tracheal cannula connected to a constantvolume ventilator (Model 680, Harvard Apparatus Co., MA, USA) at a rate of 60 breaths/min. The tidal volume was set at 6 mL/kg. Airflow was monitored continuously with a pneumotachograph (TV-241T, Nihon Koden Co., Tokyo, Japan) connected to a differential pressure transducer (TP-602T, Nihon Koden Co.). The tidal volume was calculated by electrical integration of airflow. A fluid-filled polyethylene catheter was introduced into the esophagus to measure esophageal pressure as an approximation of pleural pressure. Intratracheal pressure was measured using a polyethylene catheter inserted into a short tube connecting the tracheal cannula to the pneumotachograph. Transpulmonary pressure (defined as the difference between the intratracheal and the esophageal pressure) was measured with a differential pressure transducer. Total pulmonary resistance (RL) was calculated using methods previously described.10 Before experiments were performed, guinea-pigs were allowed 20 min to recover from the preparation procedure. To prevent alveolar atelectasis, a large inflation of three tidal volumes was performed every 5 min by occluding the expiratory valve. The effect of L-NAME on ET-1-, ET-2-or ET-3-induced bronchoconstriction
In one series of experiments, concentration curves for the response to endothelins between 10210 and 1026 mol/L (30 breaths at each concentration) were recorded for two groups of six guinea-pigs each. One group was administered aerosolized NG-nitro-L-arginine methyl ester (L-NAME) and the other aerosolized saline. In another series of experiments, pulmonary resistance in response to 1027 mol/L ET-3 was recorded.
Groups of six guinea-pigs each were given either ET-3 and L-NAME (1024 mol/L, 30 breaths), or ET-3, L-NAME and L-Arginine (1023 mol/L, 30 breaths).
Effect of L-NAME and ascorbic acid on isoproterenolor salbutamol-induced bronchodilation
In each group, guinea-pigs were randomly allocated to pretreatment with either aerosolized L-NAME (administered 20 min before ET-inhalation) or saline administered under the same conditions. We recorded the pulmonary resistance in response to isoproterenol (1024 mol/L, 30 breaths) 20 min after ET-3-administration. In additional experiments we also recorded the pulmonary resistance in response to the simultaneous aerosolized administration of 1024 mol/L isoproterenol or salbutamol and 10 23 mol/L ascorbic acid . Effect of L-NAME and ascorbic acid on isoproterenolor salbutamol-induced bronchodilator response
Aerosolized ET-1 and ET-3 each rapidly induced maximal constriction and subsequently maintained constant airway tone. Neither administration of aerosolized ascorbic acid nor isoproterenol significantly inhibited ET-3-induced bronchoconstriction, but in the presence of ascorbic acid, isoproterenol markedly inhibited ET-3-induced bronchoconstriction (Fig. 3) . However, after treatment with L-NAME, aerosolized isoproterenol significantly inhibited ET-3-induced bronchoconstriction, and no additive bronchodilatative effect was obtained by simultaneous aerosolized administration of ascorbic acid (Fig. 4) . Salbutamol, another adrenergic agent, (Fig. 5) . Aerosolized ET-1 (1027 mol/L) induced bronchoconstriction to the same extent as did ET-3 (1026 mol/L). However, isoproterenol did not significantly inhibit ET-1-induced bronchoconstriction, and the bronchodilatative effect of salbutamol was not affected by ascorbic acid (Fig. 6 ). Fig. 2 The effects of L-arginine and nitric oxide synthase inhibitor (L-NAME) on endothelin 3 (ET-3)-induced bronchoconstriction. Each NO release from guinea-pig airway remains to be determined.
Neither inhaled isoproterenol nor salbutamol significantly affected ET-3-induced bronchoconstriction, but pretreatment with L -NAME markedly enhanced isoproterenol-mediated relaxation .
We therefore suggest functioning of a number of plasma membrane proteins in the respiratory tract, including receptors (proteins involved in signal transduction) and ion channels, may require the presence of strong antioxidants. Antioxidant therapy thus appears to be an exciting new treatment for airway inflammatory disease.
